Shots:
Lonza has agreed to divest its Capsules & Health Ingredients (CHI) business to Lone Star Funds for an enterprise value of CHF 2.3B (~$3B), receiving CHF 1.7B (~$2.2B) upfront while retaining a 40% stake with preferential participation in future exit proceeds
Lonza is expecting total undiscounted proceeds of ≥CHF 3B (~$4B) from CHI via…
